• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies.

作者信息

Wellerson R, Kaplan P

出版信息

Hybridoma. 1986 Fall;5(3):199-213. doi: 10.1089/hyb.1986.5.199.

DOI:10.1089/hyb.1986.5.199
PMID:2429910
Abstract

Six anti-carcinoembryonic monoclonal antibodies (CEA MAbs) were isolated and characterized. Through blocking studies, only two were found to share the same epitope, indicating that CEA has at least five different epitopic sites. One of the group, 31C5A4 was found to enhance greatly the binding of CEA by 20C2H1. When (31C5A4) was fragmented, both the F(ab')2 and Fab bound CEA and blocked the binding of CEA by intact 31C5A4; however, only F(ab')2 was able to enhance. Fab could be induced to enhance after being restructured into a divalent form with rabbit anti-mouse (RAM) (heavy and light chains). The addition of the enhancing MAb (31C5A4) to the CEA-20C2H1 RAM-staph A (SA) complex caused a striking decrease in the rate at which the CEA dissociated from the complex. The data suggest that the enhancement observed with these anti-CEA MAbs was the result of the formation of a stable cyclic complex.

摘要

相似文献

1
Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies.
Hybridoma. 1986 Fall;5(3):199-213. doi: 10.1089/hyb.1986.5.199.
2
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.放射性标记的抗癌胚抗原单克隆抗体及其抗原结合片段在人结肠多细胞肿瘤球体中的穿透与结合
Cancer Res. 1987 Mar 15;47(6):1627-33.
3
Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion.抗癌胚抗原单克隆抗体的特异性及其对癌胚抗原介导黏附的影响。
Cancer Res. 1993 Aug 15;53(16):3817-22.
4
Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.癌胚抗原单克隆抗体:利用相关正常抗原对抗体特异性进行的系统分析以及癌胚抗原上同种异型决定簇的证据
J Immunol. 1984 Oct;133(4):2090-7.
5
Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.完全人源化的抗癌胚抗原(CEA)Gold 4表位的IgG和IgM抗体,设计用于结直肠癌的放射免疫治疗(RIT)。
BMC Cancer. 2004 Oct 15;4:75. doi: 10.1186/1471-2407-4-75.
6
Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.在癌胚抗原系统中,通过独特型网络利用单克隆抗独特型抗体诱导免疫应答。
J Cell Biochem. 1992 Nov;50(3):324-35. doi: 10.1002/jcb.240500313.
7
Swine monoclonal antibodies of high affinity and specificity to carcinoembryonic antigen.对癌胚抗原有高亲和力和特异性的猪单克隆抗体。
J Natl Cancer Inst. 1987 Aug;79(2):337-42.
8
Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA).使用针对癌胚抗原(CEA)两种不同表位的新设计双特异性抗体进行肿瘤靶向治疗。
Int J Cancer. 1999 Apr 12;81(2):285-91. doi: 10.1002/(sici)1097-0215(19990412)81:2<285::aid-ijc19>3.0.co;2-t.
9
Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.在实验性放射免疫导向手术中,使用一种新型双表位抗癌胚抗原单克隆抗体增强结直肠癌靶向性。
Int J Cancer. 2002 Feb 1;97(4):542-7. doi: 10.1002/ijc.1630.
10
Epitopes of carcinoembryonic antigen defined by monoclonal antibodies prepared from mice immunized with purified carcinoembryonic antigen or HCT-8R cells.用纯化的癌胚抗原或HCT - 8R细胞免疫小鼠制备的单克隆抗体所界定的癌胚抗原表位。
Cancer Res. 1986 Jan;46(1):300-9.

引用本文的文献

1
Antibody transport and internalization into tumours.抗体向肿瘤的转运及内化
Br J Cancer Suppl. 1990 Jul;10:1-5.